News + Filings Transactions
|
MOEBIUS HANS
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/02/2023 | Athira Pharma, Inc. | ATHA | Exercise | Stock Option (Right to Buy) | 7.9k | $1.35 | $10.6k | | 06/02/2023 |
05/18/2023 | Athira Pharma, Inc. | ATHA | Grant | | 7.8k | $2.41 | $18.7k | | 06/02/2023 |
01/19/2023 | Athira Pharma, Inc. | ATHA | Grant | Stock Option (Right to Buy) | 200k | $3.37 | $674k | | 01/19/2023 |
11/15/2022 | Athira Pharma, Inc. | ATHA | Purchase | Common Stock | 5k | $3.29 | $16.4k | | 11/15/2022 |
10/13/2022 | Athira Pharma, Inc. | ATHA | Exercise | Stock Option (Right to Buy) | 7.9k | $1.35 | $10.6k | | 10/13/2022 |
06/28/2022 | Athira Pharma, Inc. | ATHA | Purchase | Common Stock | 10k | $2.88 | $28.8k | | 06/28/2022 |
06/22/2022 | Athira Pharma, Inc. | ATHA | Grant | Common Stock | 10k | $0.00 | $0 | | 06/22/2022 |
05/18/2022 | Athira Pharma, Inc. | ATHA | Grant | | 1.7k | $7.06 | $12k | | 06/22/2022 |
01/18/2022 | Athira Pharma, Inc. | ATHA | Grant | Stock Option (Right to Buy) | 180k | $10.64 | $1.9M | | 01/18/2022 |
11/18/2021 | Athira Pharma, Inc. | ATHA | Grant | | 829 | $12.51 | $10.4k | | 01/18/2022 |
07/21/2021 | Athira Pharma, Inc. | ATHA | Exercise | Stock Option (Right to Buy) | 12.6k | $1.35 | $17k | | 07/21/2021 |
07/21/2021 | Athira Pharma, Inc. | ATHA | Exercise | Stock Option (Right to Buy) | 15.8k | $1.35 | $21.3k | | 07/21/2021 |
05/18/2021 | Athira Pharma, Inc. | ATHA | Grant | | 2.1k | $14.45 | $29.7k | | 07/21/2021 |
02/18/2021 | Athira Pharma, Inc. | ATHA | Grant | Stock Option (Right to Buy) | 72k | $21.15 | $1.5M | | 02/18/2021 |
|